top of page

This initiative has been sponsored in part by Mylan Pharmaceuticals through an educational grant. 

USING CLOZAPINE: HOW EARLY IS TOO SOON?

The Canadian Consortium for Early Intervention in Psychosis has evaluated the use of clozapine within the first two years of diagnosis of non-affective psychosis. The presentation outlines these results and covers the following educational content:

  • efficacy and effectiveness of Clozapine for treatment resistant schizophrenia (TRS)

  • use of Clozapine during the early phase of schizophrenia

  • expertise in using Clozapine in routine care

bottom of page